Difference between revisions of "Part:BBa K3096035:Design"

 
m (→‎References)
 
(One intermediate revision by the same user not shown)
Line 13: Line 13:
 
===Source===
 
===Source===
  
−
Sequence
+
Teuta Opačak-Bernardi and Jung Su Ryu and Drazen Raucher. Effects of cell penetrating Notch inhibitory peptide conjugated to elastin-like polypeptide on glioblastoma cells. Journal of Drug Targeting. Volume 25. Number 6. pages 523-531. 2017. Taylor & Francis.10.1080/1061186X.2017.1289537
  
 
===References===
 
===References===
 +
Teuta Opačak-Bernardi and Jung Su Ryu and Drazen Raucher. Effects of cell penetrating Notch inhibitory peptide conjugated to elastin-like polypeptide on glioblastoma cells. Journal of Drug Targeting. Volume 25. Number 6. pages 523-531. 2017. Taylor & Francis.10.1080/1061186X.2017.1289537

Latest revision as of 12:34, 15 October 2019


SynB1 with His-tag and GFP


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    COMPATIBLE WITH RFC[12]
  • 21
    INCOMPATIBLE WITH RFC[21]
    Illegal BamHI site found at 747
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    INCOMPATIBLE WITH RFC[25]
    Illegal AgeI site found at 806
  • 1000
    INCOMPATIBLE WITH RFC[1000]
    Illegal BsaI.rc site found at 676


Design Notes

Lab application


Source

Teuta Opačak-Bernardi and Jung Su Ryu and Drazen Raucher. Effects of cell penetrating Notch inhibitory peptide conjugated to elastin-like polypeptide on glioblastoma cells. Journal of Drug Targeting. Volume 25. Number 6. pages 523-531. 2017. Taylor & Francis.10.1080/1061186X.2017.1289537

References

Teuta Opačak-Bernardi and Jung Su Ryu and Drazen Raucher. Effects of cell penetrating Notch inhibitory peptide conjugated to elastin-like polypeptide on glioblastoma cells. Journal of Drug Targeting. Volume 25. Number 6. pages 523-531. 2017. Taylor & Francis.10.1080/1061186X.2017.1289537